PEDIATRICS Vol. 97 No. 3 March 1996, pp. 352-356
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pearson, H. A.
Right arrow Articles by Kazazian, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearson, H. A.
Right arrow Articles by Kazazian, H. H., Jr.

The Changing Profile of Homozygous beta-Thalassemia: Demography, Ethnicity, and Age Distribution of Current North American Patients and Changes in Two Decades

Howard A. Pearson MD1, Alan R. Cohen MD2, Patricia-Jane V. Giardina MD3, and Haig H. Kazazian Jr. MD4

1 The Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut
2 Departments of Pediatrics and Genetics, University of Pennsylvania School of Medicine, Philadelphia
3 Department of Pediatrics, Cornell University Medical Center, New York, New York.
4 Department of Pediatrics, Johns Hopkins University Medical Center, Baltimore, Maryland., Departments of Pediatrics and Genetics, University of Pennsylvania School of Medicine, Philadelphia

Background. The age of patients with homozygous beta-thalassemia is increasing because of better treatment and decreased births. A countering influence is immigration of ethnic groups with a high prevalence of thalassemia.

Methods. A questionnaire sent to 48 North American centers requested information about current patients with homozygous beta-thalassemia: age, clinical severity, and ethnicity. An 83% response was obtained. Twelve reference hospitals that participated in similar surveys in 1972 and 1984 were included.

Results. Five hundred eighteen patients with homozygous beta-thalassemia represent most North American patients. Four hundred forty-three (86%) of these had transfusion-dependent thalassemia major (TM); 75 (14%) had thalassemia intermedia (TI). Sixty-two percent were of Greek and Italian ancestry. There were approximately equal numbers of patients with TM in 5-year intervals between 0 and 25 years of age. Thereafter, the number of patients fell sharply. The mean age (±SD) of the patients with TM was 16.1 ± 9.2 years. Striking differences were seen in Italian and Greek patients compared with those of other ancestries. Sixty-six percent of the 271 Italian and Greek patients with TM were older than 16 years of age, whereas 77% of the 172 patients of other ethnic groups with TM were younger than 15 years of age. The mean age of the 75 patients with TI was greater than that of the patients with TM. Seventy-three percent of African-American patients with thalassemia had TI, compared with 0% of Southeastern Asian patients. Comparisons of patients with TM from the 12 reference hospitals for two decades show increasing mean ages of TM patients (1973, 11.4 ± 6.7 years; 1985, 14.2 ± 7.3 years; and 1993, 16.1 ± 9.2 years).

Conclusions. There are probably only 750 to 1000 patients with homozygous beta-thalassemia in North America. Only about 15 to 20 new cases are diagnosed each year. The increasing mean age and age distribution indicate that modern therapies are effective, but immigration of non-Mediterranean ethnic groups with thalassemia has resulted in more, younger patients. TM is increasingly becoming a disease of young adults.

Key Words: beta-thalassemia • ethnicity • young adults • incidence • prevalence • survival

Submitted on March 6, 1995
Accepted on April 17, 1995




This article has been cited by other articles:


Home page
 PediatricsHome page
E. P. Vichinsky, E. A. MacKlin, J. S. Waye, F. Lorey, and N. F. Olivieri
Changes in the Epidemiology of Thalassemia in North America: A New Minority Disease
Pediatrics, December 1, 2005; 116(6): e818 - e825.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
S. P. PERRINE, S. A. CASTANEDA, M. S. BOOSALIS, G. L. WHITE, B. M. JONES, and R. BOHACEK
Induction of Fetal Globin in {beta}-Thalassemia: Cellular Obstacles and Molecular Progress
Ann. N.Y. Acad. Sci., November 1, 2005; 1054(1): 257 - 265.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. JESSUP and C. S. MANNO
Diagnosis and Management of Iron-induced Heart Disease in Cooley's Anemia
Ann. N.Y. Acad. Sci., June 30, 1998; 850(1): 242 - 250.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
E. P. VICHINSKY
The Morbidity of Bone Disease in Thalassemia
Ann. N.Y. Acad. Sci., June 30, 1998; 850(1): 344 - 348.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
S. BUSH, F. S. MANDEL, and P. J. GIARDINA
Future Orientation and Life Expectations of Adolescents and Young Adults with Thalassemia Major
Ann. N.Y. Acad. Sci., June 30, 1998; 850(1): 361 - 369.
[Abstract] [Full Text] [PDF]